Septra and Dlb - a phase IV clinical study of FDA data

Summary:

Dlb is reported as a side effect among people who take Septra (sulfamethoxazole; trimethoprim), especially for people who are male, 60+ old, also take Pantoprazole, and have Psoriasis.

The phase IV clinical study analyzes which people have Dlb when taking Septra. It is created by eHealthMe based on reports of 9,928 people who have side effects when taking Septra from the FDA, and is updated regularly.

What is Septra?

Septra has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 10,280 Septra users. Check the latest studies of Septra.

What is Dlb?

Dlb is found to be associated with 1,981 drugs and 1,809 conditions by eHealthMe. Check the latest studies of Dlb.

On May, 27, 2026

9,928 people reported to have side effects when taking Septra.
Among them, 16 people (0.16%) have Dlb.

Among these 16 people:

What is the gender of people who have Dlb when taking Septra? *

female: 40 %
male: 60 %

What is the age of people who have Dlb when taking Septra? *

What are other drugs people take besides Septra? *

What are other side effects people have besides Dlb? *

Confusional State: 6 people, 37.50%
Fall: 5 people, 31.25%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 31.25%
Stress And Anxiety: 5 people, 31.25%
Pain: 5 people, 31.25%
Hypotension (abnormally low blood pressure): 5 people, 31.25%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 4 people, 25.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 25.00%
Pneumonia: 4 people, 25.00%
Back Pain: 4 people, 25.00%

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 3 people, 18.75%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 2 people, 12.50%
Bone Loss: 2 people, 12.50%
Neuropathy Peripheral (surface nerve damage): 1 person, 6.25%
Neuroblastoma (a cancer that forms in your nerve tissue): 1 person, 6.25%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 1 person, 6.25%
Metastases To Bone (cancer spreads to bone): 1 person, 6.25%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 6.25%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 6.25%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Septra and have Dlb?

- Check whether Dlb is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Septra:

Septra (10,280 reports)

Dlb treatments and more:

Dlb (44,271 reports)

How severe was Dlb and when was it recovered:

Dlb in Septra

Expand to all the drugs that have ingredients of sulfamethoxazole; trimethoprim:

Dlb and drugs with ingredients of sulfamethoxazole; trimethoprim (177 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Septra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dlb:

Dlb (1,981 drugs)

Browse all the conditions that are associated with Dlb:

Dlb (1,809 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim (the active ingredients of Septra) and Septra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.